Prognostic factors and outcomes in upper gastrointestinal Crohn's disease: A scoping review.
BACKGROUND: Upper gastrointestinal (UGI) involvement occurs in about 13% of patients with Crohn's disease (CD) and is variably defined across guidelines, which complicates prognosis. We mapped adult data on prognostic factors and outcomes in UGI‑CD and identified evidence gaps. METHODS: A comprehensive search strategy was applied to MEDLINE, Embase, and Cochrane Central through November 26, 2025. We included studies reporting prognostic factors in patients with UGI-CD. We synthesized evidence across 3 domains: (1) patient and disease characteristics associated with UGI involvement at diagnosis, (2) the comparative prognosis of UGI-CD vs non-UGI disease, and (3) among patients with UGI-CD, factors associated with long-term adverse outcomes. Findings were synthesized narratively. RESULTS: From 3297 screened records, 732 underwent full text assessment, and 43 primary studies were included. A total of 101 prognostic factor-outcome relationships were identified. In domain 1 (patient and disease characteristics associated with UGI involvement at diagnosis), younger age at onset was the most consistently reported factor associated with UGI involvement. In domain 2 (comparative prognosis vs non-UGI disease), studies evaluating pooled L4 disease frequently associated UGI involvement at diagnosis with higher surgical risk, incident stricture development, and adverse long-term outcomes. However, studies that distinguished anatomic subtypes suggested that risk is not uniform: jejunal/proximal small bowel disease generally followed a more aggressive course, whereas esophagogastroduodenal-limited disease appeared to have a comparatively more favorable prognosis. In domain 3 (among patients with UGI-CD, factors associated with long-term adverse outcomes), a higher Simple Endoscopic Score for Crohn's Disease was associated with subsequent surgery in a duodenal stricture cohort on univariable analysis; an independent prognostic effect was not established. CONCLUSIONS: The available literature suggests that prognosis in UGI-CD is not uniform. Jejunal/proximal small bowel disease appears to follow a more aggressive course than esophagogastroduodenal-limited disease, although interpretation is limited by predominantly retrospective designs, heterogeneous definitions, and inconsistent adjustment for confounders.
Authors
- Navneet Natt (ORCID: https://orcid.org/0000-0002-9465-7534)
- Laurent Peyrin‐Biroulet (ORCID: https://orcid.org/0000-0003-2536-6618)
- Silvio Danese (ORCID: https://orcid.org/0000-0001-7341-1351)
- Rokhsana Mortuza (ORCID: https://orcid.org/0000-0001-9586-9371)
- Rocío Sedaño (ORCID: https://orcid.org/0000-0002-3311-638X)
- Dániel Lupas (ORCID: https://orcid.org/0009-0006-1851-9734)
- Vipul Jairath (ORCID: https://orcid.org/0000-0003-1590-0338)
- Reyad Elzaanoun
- Sudheer Vuyyuru
- Yuhong Yuan
- Mohammed Shehab
- Christopher Ma
- Siddharth Singh
Institutions
- Western University (CA)
- Lawson Health Research Institute (CA)
- Vita-Salute San Raffaele University (IT)
- Inserm (FR)
- University of Calgary (CA)
- McGill University Health Centre (CA)
- Kuwait University (KW)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Mayo Clinic in Arizona (US)
- IRCCS Ospedale San Raffaele (IT)
- Nutrition-Génétique et Exposition aux Risques Environnementaux (FR)
- McGill University (CA)
- Université de Lorraine (FR)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1093/ibd/izag200
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00